Asset Details
Do you wish to reserve the book?
S783 Improvement in Fatigue With Mirikizumab Therapy Is Associated With Improvements in Patient-Reported Outcomes in Patients With Moderately-to-Severely Active Crohn's Disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
S783 Improvement in Fatigue With Mirikizumab Therapy Is Associated With Improvements in Patient-Reported Outcomes in Patients With Moderately-to-Severely Active Crohn's Disease
Do you wish to request the book?
S783 Improvement in Fatigue With Mirikizumab Therapy Is Associated With Improvements in Patient-Reported Outcomes in Patients With Moderately-to-Severely Active Crohn's Disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
S783 Improvement in Fatigue With Mirikizumab Therapy Is Associated With Improvements in Patient-Reported Outcomes in Patients With Moderately-to-Severely Active Crohn's Disease
2022
Publisher
Wolters Kluwer,Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subject
